Genmab Balance Sheet Health
Financial Health criteria checks 6/6
Genmab has a total shareholder equity of DKK31.6B and total debt of DKK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are DKK35.3B and DKK3.7B respectively. Genmab's EBIT is DKK5.3B making its interest coverage ratio -5.8. It has cash and short-term investments of DKK28.1B.
Key information
0%
Debt to equity ratio
kr.0
Debt
Interest coverage ratio | -5.8x |
Cash | kr.28.14b |
Equity | kr.31.61b |
Total liabilities | kr.3.68b |
Total assets | kr.35.29b |
Recent financial health updates
No updates
Recent updates
Genmab A/S' (CPH:GMAB) Price In Tune With Earnings
Apr 02We Think Genmab A/S' (CPH:GMAB) CEO Compensation Package Needs To Be Put Under A Microscope
Mar 07Genmab's (CPH:GMAB) Conservative Accounting Might Explain Soft Earnings
Feb 21Is Genmab A/S (CPH:GMAB) Trading At A 50% Discount?
Nov 13Is Now The Time To Put Genmab (CPH:GMAB) On Your Watchlist?
Jun 19Is There An Opportunity With Genmab A/S' (CPH:GMAB) 44% Undervaluation?
May 29With EPS Growth And More, Genmab (CPH:GMAB) Makes An Interesting Case
Mar 18Genmab A/S (CPH:GMAB) Shares Could Be 50% Below Their Intrinsic Value Estimate
Feb 27Here's Why We Think Genmab (CPH:GMAB) Is Well Worth Watching
Dec 17Are Investors Undervaluing Genmab A/S (CPH:GMAB) By 46%?
Nov 29Do Genmab's (CPH:GMAB) Earnings Warrant Your Attention?
Aug 29Financial Position Analysis
Short Term Liabilities: GMAB's short term assets (DKK33.1B) exceed its short term liabilities (DKK2.5B).
Long Term Liabilities: GMAB's short term assets (DKK33.1B) exceed its long term liabilities (DKK1.2B).
Debt to Equity History and Analysis
Debt Level: GMAB is debt free.
Reducing Debt: GMAB had no debt 5 years ago.
Debt Coverage: GMAB has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: GMAB has no debt, therefore coverage of interest payments is not a concern.